Alzheimers Dement

1. GARNIER-CRUSSARD A, Cotton F, Krolak-Salmon P, Chetelat G, et al
   White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution.
   Alzheimers Dement. 2023 Apr 7. doi: 10.1002/alz.13057.
   

   >> Share

   
   
2. HUANG CW, Rust NC, Wu HF, Yin A, et al
   Low glucose induced Alzheimer's disease-like biochemical changes in human induced pluripotent stem cell-derived neurons is due to dysregulated O-GlcNAcylation.
   Alzheimers Dement. 2023 Apr 10. doi: 10.1002/alz.13058.
   

   >> Share

   
   
3. CELIS K, Moreno MDMM, Rajabli F, Whitehead P, et al
   Ancestry-related differences in chromatin accessibility and gene expression of APOE epsilon4 are associated with Alzheimer's disease risk.
   Alzheimers Dement. 2023 Apr 10. doi: 10.1002/alz.13075.
   

   >> Share

   
   
4. VIDELA L, Benejam B, Carmona-Iragui M, Barroeta I, et al
   Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome.
   Alzheimers Dement. 2023 Apr 11. doi: 10.1002/alz.13073.
   

   >> Share

   
   
5. ZHOU RZ, Vetrano DL, Grande G, Duell F, et al
   A glycan epitope correlates with tau in serum and predicts progression to Alzheimer's disease in combination with APOE4 allele status.
   Alzheimers Dement. 2023 Apr 12. doi: 10.1002/alz.13024.
   

   >> Share

   
   
6. BAI H, Naj AC, Benchek P, Dumitrescu L, et al
   A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease.
   Alzheimers Dement. 2023 Apr 12. doi: 10.1002/alz.13050.
   

   >> Share

   
   
7. MORENO M, Kline CR, Lanigan K, Kallmyer B, et al
   Personal meaningfulness of potential FDA-approved treatments: Perspectives of individuals living with Alzheimer's disease.
   Alzheimers Dement. 2023 Apr 14. doi: 10.1002/alz.13079.
   

   >> Share

   
   

   
   Biol Psychiatry

8. ZHANG DF, Li M
   Toward a Full Understanding of Causal and Modifiable Risk Factors for Alzheimer's Disease by Integrative Phenome-wide Association Studies.
   Biol Psychiatry. 2023;93:756-758.
   

   >> Share

   
   
9. RITTMAN T
   Functional Networks: A New Window Into Alzheimer's Disease Subtypes.
   Biol Psychiatry. 2023;93:752-753.
   

   >> Share

   
   
10. GE YJ, Ou YN, Deng YT, Wu BS, et al
    Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood.
    Biol Psychiatry. 2023;93:770-779.
    

    >> Share

    
    
11. KIM Y, Park H, Kim Y, Kim SH, et al
    Pathogenic Role of RAGE in Tau Transmission and Memory Deficits.
    Biol Psychiatry. 2023;93:829-841.
    

    >> Share

    
    
12. MA LZ, Zhang YR, Li YZ, Ou YN, et al
    Cataract, Cataract Surgery, and Risk of Incident Dementia: A Prospective Cohort Study of 300,823 Participants.
    Biol Psychiatry. 2023;93:810-819.
    

    >> Share

    
    

    
    BMC Geriatr

13. JARVINEN H, Tolppanen AM, Hartikainen S
    Risk factors of pneumonia in persons with and without Alzheimer's disease: a matched cohort study.
    BMC Geriatr. 2023;23:227.
    

    >> Share

    
    
14. SHIMADA H, Makino K, Kato T, Ito K, et al
    Computer-based cognitive tests and cerebral pathology among Japanese older adults.
    BMC Geriatr. 2023;23:226.
    

    >> Share

    
    

    
    J Alzheimers Dis

15. KIM BS, Jun S, Kim H
    Cognitive Trajectories and Associated Biomarkers in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;92:803-814.
    

    >> Share

    
    
16. WELBERRY HJ, Chau T, Heffernan M, San Jose JC, et al
    Factors Associated with Participation in a Multidomain Web-Based Dementia Prevention Trial: Evidence from Maintain Your Brain (MYB).
    J Alzheimers Dis. 2023;92:959-974.
    

    >> Share

    
    
17. LI QY, Li XM, Hu HY, Ma YH, et al
    Associations of Lung Function Decline with Risks of Cognitive Impairment and Dementia: A Meta-Analysis and Systematic Review.
    J Alzheimers Dis. 2023;92:853-873.
    

    >> Share

    
    
18. KANIA B, Sotelo A, Ty D, Wisco JJ, et al
    The Prevention of Inflammation and the Maintenance of Iron and Hepcidin Homeostasis in the Gut, Liver, and Brain Pathologies.
    J Alzheimers Dis. 2023;92:769-789.
    

    >> Share

    
    
19. TARAWNEH HY, Jayakody DMP, Verma S, Dore V, et al
    Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints.
    J Alzheimers Dis. 2023;92:1093-1109.
    

    >> Share

    
    
20. JOHNSON CN, McCoin CS, Kueck PJ, Hawley AG, et al
    Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults.
    J Alzheimers Dis. 2023;92:1027-1035.
    

    >> Share

    
    
21. SULHEIM E, WiderOe M, Back M, Nilsson KPR, et al
    Contrast Enhanced Magnetic Resonance Imaging of Amyloid-beta Plaques in a Murine Alzheimer's Disease Model.
    J Alzheimers Dis. 2023 Apr 3. doi: 10.3233/JAD-220198.
    

    >> Share

    
    
22. NAGARAJA N, Wang WE, Duara R, DeKosky ST, et al
    Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-220624.
    

    >> Share

    
    
23. GARCIA-ESCOBAR G, Puig-Pijoan A, Puente-Periz V, Fernandez-Lebrero A, et al
    NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-beta and Tau Levels in the Continuum of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-220930.
    

    >> Share

    
    
24. MAO C, You H, Hou B, Chu S, et al
    Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2023 Apr 4. doi: 10.3233/JAD-221023.
    

    >> Share

    
    
25. QIAN L, Bian W, Wang D, Ming Z, et al
    Adeno-Associated Virus-Mediated Immunotherapy Based on Bispecific Tandem scFv for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-221088.
    

    >> Share

    
    
26. XU Y, Zheng F, Zhong Q, Zhu Y, et al
    Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-230002.
    

    >> Share

    
    
27. JIA J, Zhang Y, Shi Y, Yina X, et al
    Erratum to: A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 5. doi: 10.3233/JAD-239001.
    

    >> Share

    
    

    
    J Am Geriatr Soc

28. BURGDORF JG, Amjad H
    Impact of diagnosed (vs undiagnosed) dementia on family caregiving experiences.
    J Am Geriatr Soc. 2023;71:1236-1242.
    

    >> Share

    
    
29. COLE CS, Carpenter JS, Blackburn J, Chen CX, et al
    Pain trajectories of nursing home residents.
    J Am Geriatr Soc. 2023;71:1188-1197.
    

    >> Share

    
    

    
    J Biol Chem

30. LU Y, Huang X, Liang W, Li Y, et al
    Regulation of TREM2 expression by transcription factor YY1 and its protective effect against Alzheimer's Disease.
    J Biol Chem. 2023 Apr 10:104688. doi: 10.1016/j.jbc.2023.104688.
    

    >> Share

    
    

    
    Neurobiol Aging

31. WIGHTMAN DP, Savage JE, Tissink E, Romero C, et al
    The genetic overlap between Alzheimer's disease, amyotrophic lateral sclerosis, Lewy body dementia, and Parkinson's disease.
    Neurobiol Aging. 2023 Mar 12:S0197-4580(23)00050.
    

    >> Share

    
    
32. KASUGA K, Tsukie T, Kikuchi M, Tokutake T, et al
    The clinical application of optimized AT(N) classification in Alzheimer's clinical syndrome (ACS) and non-ACS conditions.
    Neurobiol Aging. 2023;127:23-32.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

33. LOPEZ-CUEVAS R, Baquero-Toledo M, Cuevas-Jimenez A, Martin-Ibanez N, et al
    Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease.
    Neurologia (Engl Ed). 2023 Apr 7:S2173-5808(23)00006.
    

    >> Share

    
    

    
    PLoS One

34. FAISAL M, Aid J, Nodirov B, Lee B, et al
    Preclinical trials in Alzheimer's disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice.
    PLoS One. 2023;18:e0281003.
    

    >> Share

    
    

    
    Science

35. PILLER C
    Report on trial death stokes Alzheimer's drug fears.
    Science. 2023;380:122-123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share